Danaparoid sodium prevents cerulein-induced acute pancreatitis in rats

Shock

Volumn 32, Issue 1, 2009, Pages 94-99

  Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Uchida, Tomohisa ^a   Hasegawa, Akira ^a   Asai, Nobuhiko ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Anticoagulant; High mobility group box 1; Inflammation; NO

Indexed keywords

CERULETIDE; DANAPAROID; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NONHUMAN; PANCREAS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RAT; SERUM; WISTAR RAT;

ANIMALS; BLOTTING, WESTERN; CAERULEIN; CHONDROITIN SULFATES; DERMATAN SULFATE; FIBRINOLYTIC AGENTS; HEPARITIN SULFATE; HMGB1 PROTEIN; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; NF-KAPPA B; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PANCREAS; PANCREATITIS; PEROXIDASE; RATS;

EID: 67749086619     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818ec2c2     Document Type: Article

References (35)

1. Renzulli P, Jakob SM, Täuber M, Candinas D, Gloor B: Severe acute pancreatitis: case-oriented discussion of interdisciplinary management. Pancreatology 5:145-156, 2005.
2. Schneider L, Pietschmann M, Hartwig W, Marcos SS, Hackert T, Gebhard MM, Uhl W, Büchler MW, Werner J: Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg 191:510-514, 2006.
3. Granger J, Remick D: Acute pancreatitis: models, markers, and mediators. Shock 24(suppl 1):45-51, 2005.
4. Zhang XP, Lin Q, Zhou YF: Progress of study on the relationship between mediators of inflammation and apoptosis in acute pancreatitis. Dig Dis Sci 52(5):1199-1205, 2007.
5. Iba T, Kidokoro A, Yagi Y: The role of the endothelium in changes in procoagulant activity. J Am Coll Surg 87:321-329, 1998.
6. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R: Proteinase-activated receptors. Pharmacol Rev 53:245-282, 2001.
7. Bustin M: Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19:5237-5246, 1999.
8. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al.: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251, 1999.
9. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF: Inflammation-promoting activity of HMGB1 on human micro vascular endothelial cells. Blood 101:2652-2660, 2003.
10. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, et al.: Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol 293:R1538-R1544, 2007.
11. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y: Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 33:359-363, 2006.
12. Dumas R, Woitinas F, Kutnowski M, Nikolic I, Berberich R, Abedinpour F, Zoeckler S, Gregoire F, Jerkovic M, Egberts JF, et al.: A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke. Age Ageing 6:512-516, 1994.
13. Meuleman DG: Orgaran (Org10172): its pharmacological profile in experimental models. Haemostasis 22:58-65, 1992.
14. Iba T, Kidokoro A, Fukunaga M, Fuse S, Suda M, Kunitada S, Hara T: Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat. Shock 17:159-162, 2002.
15. Iba T, Kidokoro A, Fukunaga M, Nagakari K, Suda M, Yoshikawa S, Ida Y: Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin. Intensive Care Med 31:1101-1108, 2005.
16. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S, Noguchi T: Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 12:R43, 2008.
17. Virlos I, Mazzon E, Serraino I, Di Paola R, Genovese T, Britti D, Thiemerman C, Siriwardena A, Cuzzocrea S: Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 20:544-550, 2003.
18. Koike K, Moore FA, Moore EE, Poggetti RS, Tuder RM, Banerjee A: Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 52:656-662, 1992.
19. Kakafika A, Papadopoulos V, Mimidis K, Mikhailidis DP: Coagulation, platelets, and acute pancreatitis. Pancreas 34:15-20, 2007.
20. Feistritzer C, Wiedermann CJ: Effects of anticoagulant strategies on activation of inflammation and coagulation. Expert Opin Biol Ther 7:855-870, 2007.
21. Granger J, Remick D: Acute pancreatitis: models, markers, and mediators. Shock 24:45-51, 2005.
22. Voll RE, Urbonaviciute V, Herrmann M, Kalden JR: High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr Med Assoc J 10:26-28, 2008.
23. Mantell LL, Parrish WR, Ulloa L: Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25:4-11, 2006.
24. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T, Kuroda Y: Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12:7666-7670, 2006.
25. Esmon CT: The interactions between inflammation and coagulation. Br J Haematol 131:417-430, 2005.
26. Sweiry JH, Mann GE: Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol 219:10-15, 1996.
27. Dabrowski A, Gabryelewicz A: Nitric oxide contributes to multiorgan oxidative stress in acute pancreatitis. Scand J Gastroenterol 29:943-948, 1994.
28. Jiang W, Pisetsky DS: The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J Immunol 177:3337-3343, 2006.
29. Rakonczay Z Jr, Hegyi P, Takács T, McCarroll J, Saluja AK: The role of NFkappaB activation in the pathogenesis of acute pancreatitis. Gut 57:259-267, 2008.
30. Adcock IM: Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis 52:178-186, 1997.
31. Ethridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajaraman S, Evers BM: Selective inhibition of NF-kappaB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg 195:497-505, 2002.
32. Esmon CT: Role of coagulation inhibitors in inflammation. Thromb Haemost 86:51-56, 2001.
33. Riewald M, Kravchenko VV, Petrovan RJ, O'Brien PJ, Brass LF, Ulevitch RJ, Ruf W: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97:3109-3116, 2001.
34. Skoutakis VA: Danaparoid in the prevention of thromboembolic complications. Ann Pharmacother 31:876-887, 1997.
35. Eikelboom JW, Hankey GJ. Low molecular weight heparins and heparinoids. Med J Aust 7:379-383, 2002.